UB-851
NDA- Indications
- Anemia
Company intelligence / Profile preview
UBI Pharma
Hukou Township/Hsinchu City, Hsinchu, Taiwanen.ubi-pharma.com ↗
- Ownership
- Public · 6562
- Employees
- ~300
- Development stage
- Commercial
01
Overview
UBI Pharma has successfully commercialized multiple specialty generic injectables and long‐acting protein drugs. The company’s proprietary Voriconazole Injection received ANDA approval from the US FDA. Its biosimilar erythropoietin product UB‐851 has been submitted for regulatory review in Taiwan. The company’s manufacturing site has passed inspections by the US FDA and Japan PMDA.
- Therapeutic areas
- NeurologyInfectious DiseasesNephrology
- Modalities
- Long-acting protein drugsSmall moleculeBiologicBiosimilarPeptideLyophilized formulation
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Merdury Biopharmaceutical Corporation for sildenafil orally disintegrating tablets developmentTaiwan Centers for Disease Control for vaccine manufacturing contractsGlaxoSmithKline heritage partnership experience cited but not current partnership
Beyond the preview
Go deeper on UBI Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UBI Pharma.